Silence Study - Longitudinal study on the use of aspirin versus placebo in patients with silent cerebral infarcts

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-000996-16-IT

Enrollment

350

Registered

2006-03-13

Start date

2004-06-30

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prevention of occlusive ischemic events in patient with transient ischemic attacs or after brain infarct, MedDRA version: 6.1 Level: HLGT Classification code 10047066

Interventions

Trade Name: ASPIRINETTA 100MG 24 CPR Pharmaceutical Form: Tablet INN or Proposed INN: Acetylsalicylic acid CAS Number: 50-78-2 Concentration unit: mg milligram(s) Concentration type: equal Concentrati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026